RE: Another day closer to phase 1 clinical trial start date15 May 2024 16:10
Final Results outline from Prof Sir Marc Feldmann AC, FRS MB BS, PhD, FRCP, FRCPath, FAA, F Med Sci
Chairman:
"Also, crucially, in September 2023, Hemogenyx Pharmaceuticals contracted with Infoworks, a well-established and experienced contract research organisation ("CRO"), through a Master Services and Contract Agreement for Infoworks to provide clinical services and technologies for the forthcoming Phase I clinical trials over an initial term of 40 months".